Our recent structure of CBL-B in complex with N-Aryl isoindolin-1-one inhibitor is now released. rcsb.org/3d-view/8GCY/1 #E3ligase

Exciting to share that our DCAF1 manuscript is now available online. It was great collaborating with the OICR team to advance this molecule into a nanomolar affinity DCAF1 ligand.

WDR proteins are a large, druggable, and underexplored target class with strong disease associations. Levon just released several WDR structures in complex with inhibitors, which were identified using DEL-ML, in collaboration with Relay Therapeutics, X-Chem and Google.

Structural and biophysical characterization of a small molecule binding to Cbl-b E3 ligase reveals an intermolecular glue mechanism locking the protein in an inactive state: nature.com/articles/s4200… Levon Structural Genomics Consortium (SGC)

A comprehensive study by Levon reveals the interaction of a small molecule which binds to Cbl-b and acts as an intramolecular glue locking the protein in an inactive state. Read more: nature.com/articles/s4200…

New Blog Post 📢 Learn how Levon utilizes AI-driven hit-finding technologies to discover small molecules targeting the WDR protein family and help elucidate the dark proteome. #OpenScience #drugdiscovery #AI thesgc.org/node/1649725

Our recent crystal structure of TREX1 in complex with a small molecule inhibitor is now available online. #drugdiscovery #cachechallenge rcsb.org/structure/8VL7